The Efficacy and Tolerability of Methylphenidate and Behavior Modification in Children with Attention-Deficit/Hyperactivity Disorder and Severe Mood Dysregulation
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: This study examines the tolerability and efficacy of methylphenidate (MPH) and behavior modification therapy (BMOD) in children with attention-deficity/hyperactivity disorder (ADHD) and severe mood dysregulation (SMD). METHODS: Children (ages 5-12) from a summer program for ADHD were screened for SMD and additional manic-like symptoms using structured assessments and direct clinical interview with the Young Mania Rating Scale (YMRS). The SMD group was comprised of 33 subjects with SMD and elevated YMRS scores (mean = 23.7). They underwent weekly mood assessments plus the daily ADHD measures that are part of the program. The comparison group (n = 68) was comprised of the rest of the program participants. Using a crossover design, all subjects in both groups were treated with three varying intensities of BMOD (no, low, high) each lasting 3 weeks, with MPH dose (placebo, 0.15 mg/kg t.i.d., 0.3mg/kg t.i.d., and 0.6 mg/kg t.i.d.) varying daily within each behavioral treatment. RESULTS: Groups had comparable ADHD symptoms at baseline, with the SMD group manifesting more oppositional defiant disorder/conduct disorder (ODD/CD) symptoms (p < 0.001). Both groups showed robust improvement in externalizing symptoms (p < 0.001). There was no evidence of differential treatment efficacy or tolerability. Treatment produced a 34% reduction in YMRS ratings in SMD subjects (p - 0.001). However, they still exhibited elevated YMRS ratings, more ODD/CD symptoms (p < 0.001), and were more likely to remain significantly impaired at home than non-SMD subjects (p < 0.05). CONCLUSIONS: MPH and BMOD are tolerable and effective treatments for children with ADHD and SMD, but additional treatments may be needed to optimize their functioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 1×
“…BP directly interviewed all subjects and their parents who met SMD criteria using the Young Mania Rating Scale (YMRS), the Children’s Depression Rating Scale Revised (CDRS-R), and Clinical Global Impressions Scale (CGI) for MDD and BP (Guy 1976; Young et al. 1978; Poznanski and Mikos 1996).”
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
SWANSON, J. M., KRAEMER, H. C., HINSHAW, S. P., ARNOLD, L. E., CONNERS, C. K., ABIKOFF, H. B., CLEVENGER, W., DAVIES, M., ELLIOTT, G. R., GREENHILL, L. L., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00011 · Cited by 1,157 · cited 1×
“In the MTA, BMOD improved ADHD symptoms, and adding BMOD to stimulants improved symptoms of conduct disorder (CD), ODD, and parent–child and peer relations (Jensen et al. 2001; Swanson et al. 2001).”
Self-citationBirmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056 · cited 1×
“These results are consistent with published findings that mild depressive symptoms respond to supportive treatments (Birmaher and Brent 2007) and the recommendation to treat ADHD before depression, except in cases where the depressive symptoms are severe (Pliszka et al. 2006).”
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974 · cited 3×
“In the MTA, BMOD improved ADHD symptoms, and adding BMOD to stimulants improved symptoms of conduct disorder (CD), ODD, and parent–child and peer relations (Jensen et al. 2001; Swanson et al. 2001).”
Self-citationGreenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder
Pelham, W. E., & Fabiano, G. A. (2008) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374410701818681 · Cited by 917 · cited 2×
“Similar crossover designs using treat-ment conditions intermixed with nontreatment conditions have been widely employed in behavioral treatments studies (Fabiano et al. 2007; Pelham and Fabiano, 2008).”
Self-citationCOMPTON, S. N., MARCH, J. S., BRENT, D., ALBANO, A. M., WEERSING, V. R., & CURRY, J. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000127589.57468.bf · Cited by 616
Cited by
The Status of Irritability in Psychiatry: A Conceptual and Quantitative Review
Vidal-Ribas, P., Brotman, M. A., Valdivieso, I., Leibenluft, E., & Stringaris, A. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.04.014 · Cited by 471
Daley, D., van der Oord, S., Ferrin, M., Danckaerts, M., Doepfner, M., Cortese, S., & Sonuga-Barke, E. J. S. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.05.013 · Cited by 401
Irritability in Youths: A Translational Model
Brotman, M. A., Kircanski, K., Stringaris, A., Pine, D. S., & Leibenluft, E. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16070839 · Cited by 362
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
ADHD and emotion dysregulation among children and adolescents
Bunford, N., Evans, S. W., & Wymbs, F. (2015) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-015-0187-5 · Cited by 306
“Waxmonsky et al. (2013) developed a group therapy for children with ADHD and SMD wherein elements of cognitive–behavioral therapy, emotion regulation techniques, and parent training are combined.”
BackgroundInfluentialThe vigilance regulation model of affective disorders and ADHD
Hegerl, U., & Hensch, T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.008 · Cited by 212
Irritability in child and adolescent psychopathology: An integrative review for ICD-11
Evans, S. C., Burke, J. D., Roberts, M. C., Fite, P. J., Lochman, J. E., de la Peña, F. R., & Reed, G. M. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.01.004 · Cited by 186
Storebø, O. J., Skoog, M., Damm, D., Thomsen, P. H., Simonsen, E., & Gluud, C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008223.pub2 · Cited by 149
Disruptive Mood Dysregulation Disorder: A New Diagnostic Approach to Chronic Irritability in Youth
Roy, A. K., Lopes, V., & Klein, R. G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13101301 · Cited by 117
Executive Functioning and Emotion Regulation in Children with and without ADHD
Groves, N. B., Wells, E. L., Soto, E. F., Marsh, C. L., Jaisle, E. M., Harvey, T. K., & Kofler, M. J. (2022) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-021-00883-0 · Cited by 110
Waxmonsky, J. G., Waschbusch, D. A., Belin, P., Li, T., Babocsai, L., Humphery, H., Pariseau, M. E., Babinski, D. E., Hoffman, M. T., Haak, J. L., et al. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.12.011 · Cited by 87
Self-citationAn Examination of Relations Among Working Memory, ADHD Symptoms, and Emotion Regulation
Groves, N. B., Kofler, M. J., Wells, E. L., Day, T. N., & Chan, E. S. M. (2020) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-019-00612-8 · Cited by 75
Sonuga-Barke, E. J. S., Coghill, D., Wigal, T., DeBacker, M., & Swanson, J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0024 · Cited by 71
“These effects are consistent with the literature that sees these items as baseline characteristic of ADHD (Efron et al. 1997) and also with previous evidence for the therapeutic benefits of MPH on emotional liability (Waxmonsky et al. 2008).”
Rucklidge, J. J., Harrison, R., & Johnstone, J. (2011) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2010.0499 · Cited by 16
Baweja, R., Waschbusch, D. A., Pelham, W. E., Pelham, W. E., & Waxmonsky, J. G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.699687 · Cited by 11
“Impairment findings are consistent with prior reports documenting appreciably disturbed functioning across a wide range of domains in youth with persistent irritability compared to youth with ADHD without prominent irritability (1, 8).”
ResultSelf-citationLittle, K., Raiker, J., Coxe, S., Campez, M., Jusko, M., Smith, J., Gnagy, E., Greiner, A., Villodas, M., Coles, E., et al. (2021) · Psychological Reports · doi:10.1177/0033294120957239 · Cited by 3
“…in this study was lower than desired, the characteristics of the children participating in the current study (e.g., DBD-RS scores, age, gender) are largely consistent with children participating in past studies from this and similar treatment programs (Morris et al., 2020; Waxmonsky et al., 2008).”
ResultSelf-citation
Metadata
- Authors
- Waxmonsky, J., Pelham, W. E., Gnagy, E., Cummings, M. R., O'Connor, B., Majumdar, A., Verley, J., Hoffman, M. T., Massetti, G. A., Burrows-MacLean, L., Fabiano, G. A., Waschbusch, D. A., Chacko, A., Arnold, F. W., Walker, K. S., Garefino, A. C., & Robb, J. A.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-12
- Volume
- 18
- Issue
- 6
- Pages
- 573-588
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2063409270
- Cited by
- 138
- References
- 16
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.